These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 8950499)
1. The pharmacology and effectiveness of specific lipid-active drugs: estrogen/sex steroids. LaRosa JC Coron Artery Dis; 1996 Sep; 7(9):683-8. PubMed ID: 8950499 [TBL] [Abstract][Full Text] [Related]
2. Increased coronary events, HERS, and HRT: any connection? Rebar RW; Archer D Arch Intern Med; 2001 May; 161(10):1350-1. PubMed ID: 11371266 [No Abstract] [Full Text] [Related]
3. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins. Crook D; Godsland IF; Wynn V Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1612-20. PubMed ID: 3287933 [TBL] [Abstract][Full Text] [Related]
4. Progestins and androgens. Whitehead M Fertil Steril; 1994 Dec; 62(6 Suppl 2):161S-167S. PubMed ID: 7958012 [TBL] [Abstract][Full Text] [Related]
5. Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin Therapy. Johnson KC; Aragaki AK; Jackson R; Reiner A; Sandset PM; Rosing J; Dahm AE; Rosendaal F; Manson JE; Martin LW; Liu S; Kuller LH; Cushman M; Rossouw JE Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):418-24. PubMed ID: 26681757 [TBL] [Abstract][Full Text] [Related]
6. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol. Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785 [TBL] [Abstract][Full Text] [Related]
7. Re: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. Kuller LH J Natl Cancer Inst; 2000 Jul; 92(13):1100-1. PubMed ID: 10880556 [No Abstract] [Full Text] [Related]
8. Estrogen-progestin replacement therapy and endometrial cancer. Pike MC; Peters RK; Cozen W; Probst-Hensch NM; Felix JC; Wan PC; Mack TM J Natl Cancer Inst; 1997 Aug; 89(15):1110-6. PubMed ID: 9262248 [TBL] [Abstract][Full Text] [Related]
10. Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins. Crook D; Cust MP; Gangar KF; Worthington M; Hillard TC; Stevenson JC; Whitehead MI; Wynn V Am J Obstet Gynecol; 1992 Mar; 166(3):950-5. PubMed ID: 1550171 [TBL] [Abstract][Full Text] [Related]
11. Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study. Simon JA; Hunninghake DB; Agarwal SK; Lin F; Cauley JA; Ireland CC; Pickar JH Ann Intern Med; 2001 Oct; 135(7):493-501. PubMed ID: 11578152 [TBL] [Abstract][Full Text] [Related]
12. Re: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. Archer DF; Bush T; Nachtigall LE J Natl Cancer Inst; 2000 Dec; 92(23):1950-2. PubMed ID: 11106695 [No Abstract] [Full Text] [Related]
13. Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis. Farris M; Bastianelli C; Rosato E; Brosens I; Benagiano G Expert Rev Clin Pharmacol; 2017 Oct; 10(10):1129-1144. PubMed ID: 28712325 [TBL] [Abstract][Full Text] [Related]
14. Lipid and lipoprotein changes in relation to oral contraception and hormonal replacement therapy. Burkman RT Fertil Steril; 1988 May; 49(5 Suppl 2):39S-50S. PubMed ID: 3282934 [TBL] [Abstract][Full Text] [Related]